A clinical study to see the effect of an Ayurvedic formulation in the treatment of Chronic Simple Rhinitis(common cold).

Phase 1

Completed

Conditions: Health Condition 1: J310- Chronic rhinitis

Registration Number: CTRI/2020/03/023837

Lead Sponsor: Sane Guruji Arogya Kendra

Brief Summary: Not available

Detailed Description: Not available

Recruitment & Eligibility

Status: Completed

Sex: Not specified

Target Recruitment: 0

Inclusion Criteria

1) Patients from age group of 20 to 50 years.

2) Patients irrespective of gender and religion.

3) Patients having signs and signs and symptoms of Peenasaa Vyadhi(Chronic SimpleRhinitis) like Nasal Obstruction, Post-Nasal Drip, Partial loss of Smell(Anosmia).

Exclusion Criteria

1) Patients suffering from known case of chronic specific infective rhinitis like Syphilis, leprosy, T.B. lupus Vulgaris, Rhinosporidiosis, Rhinoscleroma, fungal Infections, leishmaniasis.

2) Patients with systemic diseases and known case of Hypertension, Respiratory disorder, Diabetes Mellitus, HBsAg, HIV.

3) Patients with DNS, Nasal polyp, Asthma, Tumors or any nasal pathology.

4) Patient not willing for treatment and irregular follow up.

Study & Design

Study Type: Interventional

Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
A clinical study to evaluate efficacy <br/ ><br>of Katphaladi Churna in Peenasa Vyadhi w.r.t Chronic Simple RhinitisTimepoint: The drug will be given 15 days. The patients will <br/ ><br>be assessed before and after treatment. Total <br/ ><br>duration of the study will 18 months.

Secondary Outcome Measures

Name	Time	Method
A comparison between efficacy <br/ ><br>of Katphaladi Churna and Tab Levocetrizine 5mg in combination with Montelukast 10mg in Peenasa Vyadhi w.r.t Chronic Simple RhinitisTimepoint: Total duration of study is 18 Months